CARD9 p.Glu500=
c.1500G>A · rs1430111733 · VCV1138850
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 1.6 | GERP -1.3, phastCons 1 |
| Overall | ||
| CADD | 9.603 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.00334% | 29,984 |
| Admixed Americangrpmax | 0.00196% | 50,990 |
| African / African-American | 0.00137% | 73,042 |
| European (non-Finnish) | 0.000174% | 573,427 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CARD9
- Protein
- p.Glu500=
- Coding
- c.1500G>A
- MANE Select
- NM_052813
- dbSNP
- rs1430111733
- Type
- single nucleotide variant
- Location
- chr9:136364494 (GRCh38)
- Gene constraint
- LOEUF 1.143 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 81.24 · 8 PDB
- Residue 500
- the 'disordered' region; a UniProt-annotated variant site (in imd103; reduced cytokine production in response to c.albicans infection; impaired nf-kappa-b transcriptional activity); a UniProt-annotated variant site (in imd103; decreased production of cytokines in cd4(+) th17 cells); a UniProt-annotated variant site (in imd103; reduced production igg antibodies in response to c.albicans infection); a UniProt-annotated variant site (in imd103; reduced cytokine production in response to c.albicans infection)
Disease context
predisposition to invasive fungal disease due to CARD9 deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Predisposition to invasive fungal disease due to CARD9 deficiency (Orphanet):
- Inheritance
- Autosomal recessive
Similar variants
- CARD9 p.Glu500Asp Uncertain significance ★ ⚠ same residue
- CARD9 p.Gln289Ter Pathogenic ★★ same condition
- CARD9 p.Gln295Ter Pathogenic ★★ same condition
- CARD9 c.-126C>A Uncertain significance ★★ same condition
- CARD9 p.Ala109Val Uncertain significance ★★ ⚠ same condition
- CARD9 p.Ala190Val Uncertain significance ★★ ⚠ same condition
- CARD9 p.Ala198Thr Uncertain significance ★★ ⚠ same condition
- CARD9 p.Ala199Val Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/card9-p-glu500 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown